| 17beta-estradiol | multiple interactions | ISO | RGD:1347683 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of BIK mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | affects expression | ISO | RGD:1347683 | 6480464 | Estradiol affects the expression of BIK mRNA | CTD | PMID:21826169 |
| 17beta-estradiol | increases expression | ISO | RGD:1347683 | 6480464 | Estradiol results in increased expression of BIK protein | CTD | PMID:17638070 |
| 17beta-estradiol | decreases expression | ISO | RGD:1347683 | 6480464 | Estradiol results in decreased expression of BIK mRNA | CTD | PMID:19619570 |
| 1H-pyrazole | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BIK mRNA | CTD | PMID:16610055 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1347683 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BIK mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1347683 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BIK mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BIK mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1347683 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of BIK mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732887 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BIK mRNA | CTD | PMID:14718646 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1347683 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BIK mRNA | CTD | PMID:20106945 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:732887 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of BIK mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347683 | 6480464 | [decitabine co-treated with Depsipeptides] results in increased expression of BIK mRNA; more ... | CTD | PMID:17064661 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347683 | 6480464 | decitabine inhibits the reaction [Smoke results in decreased expression of BIK mRNA] | CTD | PMID:21095227 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1347683 | 6480464 | decitabine results in increased expression of BIK protein | CTD | PMID:17064661 |
| 5-azacytidine | multiple interactions | EXP | | 6480464 | [Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in increased expression of BIK mRNA; more ... | CTD | PMID:21224363 |
| 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of BIK mRNA | CTD | PMID:21224363 |
| aflatoxin B1 | affects expression | ISO | RGD:1347683 | 6480464 | Aflatoxin B1 affects the expression of BIK protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1347683 | 6480464 | Aflatoxin B1 results in increased expression of BIK mRNA | CTD | PMID:21641981 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BIK mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:1347683 | 6480464 | Benzo(a)pyrene results in increased expression of BIK mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:1347683 | 6480464 | Benzo(a)pyrene results in increased expression of BIK mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:732887 | 6480464 | Benzo(a)pyrene results in increased expression of BIK mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1347683 | 6480464 | Benzo(a)pyrene results in increased expression of BIK mRNA | CTD | PMID:20106945 PMID:22316170 |
| bisphenol A | affects expression | ISO | RGD:1347683 | 6480464 | bisphenol A affects the expression of BIK mRNA | CTD | PMID:21826169 |
| cholesterol | increases expression | EXP | | 6480464 | Cholesterol analog results in increased expression of BIK mRNA | CTD | PMID:19477266 |
| cisplatin | increases expression | ISO | RGD:1347683 | 6480464 | Cisplatin results in increased expression of BIK mRNA | CTD | PMID:20878077 |
| cisplatin | multiple interactions | ISO | RGD:1347683 | 6480464 | Y 27632 inhibits the reaction [Cisplatin results in increased expression of BIK mRNA] | CTD | PMID:20878077 |
| clozapine | multiple interactions | ISO | RGD:1347683 | 6480464 | CSF3 protein inhibits the reaction [Clozapine results in increased expression of BIK mRNA] | CTD | PMID:16160616 |
| clozapine | increases expression | ISO | RGD:1347683 | 6480464 | Clozapine results in increased expression of BIK mRNA | CTD | PMID:16160616 |
| cocaine | affects expression | ISO | RGD:732887 | 6480464 | Cocaine affects the expression of BIK mRNA | CTD | PMID:15681117 |
| copper(2+) sulfate | increases expression | ISO | RGD:1347683 | 6480464 | Copper Sulfate results in increased expression of BIK mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:1347683 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA | CTD | PMID:19167446 |
| cyclophosphamide | decreases expression | ISO | RGD:1347683 | 6480464 | Cyclophosphamide results in decreased expression of BIK mRNA | CTD | PMID:17403535 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of BIK mRNA | CTD | PMID:19730151 |
| dibutyl phthalate | increases expression | ISO | RGD:732887 | 6480464 | Dibutyl Phthalate results in increased expression of BIK mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:732887 | 6480464 | Dibutyl Phthalate results in increased expression of BIK mRNA | CTD | PMID:17361019 PMID:21266533 |
| disodium selenite | decreases expression | ISO | RGD:1347683 | 6480464 | Sodium Selenite results in decreased expression of BIK mRNA | CTD | PMID:18175754 |
| doxorubicin | increases response to substance | ISO | RGD:1347683 | 6480464 | BIK protein results in increased susceptibility to Doxorubicin | CTD | PMID:16007125 |
| doxorubicin | decreases expression | ISO | RGD:1347683 | 6480464 | Doxorubicin results in decreased expression of BIK mRNA | CTD | PMID:16705698 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BIK mRNA | CTD | PMID:16610055 |
| etoposide | increases response to substance | ISO | RGD:1347683 | 6480464 | BIK protein results in increased susceptibility to Etoposide | CTD | PMID:16007125 |
| fonofos | increases methylation | ISO | RGD:1347683 | 6480464 | Fonofos results in increased methylation of BIK promoter | CTD | PMID:22847954 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of BIK mRNA | CTD | PMID:20562052 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of BIK mRNA | CTD | PMID:20562052 PMID:22079235 |
| furosemide | affects expression | EXP | | 6480464 | Furosemide affects the expression of BIK mRNA | CTD | PMID:17497460 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of BIK mRNA | CTD | PMID:23208426 |
| olanzapine | increases expression | ISO | RGD:1347683 | 6480464 | olanzapine results in increased expression of BIK mRNA | CTD | PMID:16160616 |
| parathion | increases methylation | ISO | RGD:1347683 | 6480464 | Parathion results in increased methylation of BIK promoter | CTD | PMID:22847954 |
| phenobarbital | increases expression | ISO | RGD:732887 | 6480464 | Phenobarbital results in increased expression of BIK mRNA | CTD | PMID:19482888 |
| propiconazole | decreases expression | ISO | RGD:732887 | 6480464 | propiconazole results in decreased expression of BIK mRNA | CTD | PMID:21278054 |
| quercetin | increases expression | ISO | RGD:1347683 | 6480464 | Quercetin results in increased expression of BIK mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1347683 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA | CTD | PMID:19167446 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of BIK mRNA | CTD | PMID:21515302 |
| tamoxifen | multiple interactions | ISO | RGD:1347683 | 6480464 | ESR2 protein promotes the reaction [Tamoxifen results in increased expression of BIK protein] | CTD | PMID:17638070 |
| terbufos | increases methylation | ISO | RGD:1347683 | 6480464 | terbufos results in increased methylation of BIK promoter | CTD | PMID:22847954 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BIK mRNA | CTD | PMID:16610055 |
| trans-resveratrol | multiple interactions | ISO | RGD:1347683 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | decreases expression | ISO | RGD:732887 | 6480464 | trimellitic anhydride results in decreased expression of BIK mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of BIK mRNA | CTD | PMID:21515302 |
| urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of BIK mRNA | CTD | PMID:16978161 |
| zinc atom | increases expression | ISO | RGD:1347683 | 6480464 | Zinc deficiency results in increased expression of BIK mRNA | CTD | PMID:22171008 |
| zinc(0) | increases expression | ISO | RGD:1347683 | 6480464 | Zinc deficiency results in increased expression of BIK mRNA | CTD | PMID:22171008 |